Tag Archives: Comtan

Comtan, Stalevo Not Linked To Cardiovascular Risks: FDA

October 27, 2015 By: Irvin Jackson

FDA investigators have found no clear link between heart attack risk and the Parkinson's disease drugs Stalevo and Comtan following a five-year review.
FDA Reviewing Potential Safety Problems With Sutent, Relistor, Other Drugs

October 08, 2009 By: AboutLawsuits

The FDA has released its quarterly list of drugs that are being reviewing for potential safety problems, which includes the cancer drug Sutent, the anti-constipation medication Relistor and 11 other…

Judge Requires 3M CEO Attend Combat Arms Earplug Settlement Negotiation Session (Posted 7 days ago)

A federal judge has ordered the CEO of 3M Company to attend settlement negotiations over Combat Arms earplugs hearing loss litigation.

Master Complaint For Hair Relaxer Lawsuits Filed in Federal MDL (Posted 8 days ago)

Plaintiffs have filed a Master Complaint in consolidated hair relaxer litigation, which will help make direct filing of cases to the MDL court easier.

Judge Seeks To Clean Up Paraquat Lawsuits Pending on MDL Docket As Cases Move Toward Trial (Posted 12 days ago)

A federal judge has ordered parties to sift through Paraquat lawsuits to identify cases which are unlikely to move forward based on patient deaths and implausible theories of proof.

Tag Archives: Comtan

Comtan, Stalevo Not Linked To Cardiovascular Risks: FDA

FDA Reviewing Potential Safety Problems With Sutent, Relistor, Other Drugs

More Top Stories

Review A Case